With all the talk about it in the scientific community, there is probably no surprise that this is yet another article discussing CRISPR. However, this may be one of the most profound discussions around the technology as it involves what could arguably be the potential flagship use of the gene editing tool – human therapy.
COFFEE BREAK NEWS FOR LIFE SCIENTISTS
Lately, a major step forward has been made in using CRISPR technology in neurosciences. Over the past few years, scientists have been using gene sequencing to uncover genes that are important in brain development and in neurological diseases. The next step is to figure out if disrupting these genes can cause any of these diseases.
One of the hottest trends in life sciences research for the past few years has been the development of subfields of study focused on specific, complex networks within biological systems. These subfields are quite recognizable due to the common suffix ‘-ome’, and there is now an exciting and extensive list of “omes” starting with arguably the grandfather of them all, the genome.
Meet Prof. Dr. Tatjana Avšič, the leading scientist behind the first proof of the association between Zika virus and microcephaly in the world.
Extraction of DNA before its amplification is an essential step for the measurement of any DNA target. It releases the DNA and removes substances inhibitory to PCR that are initially present in the matrix.
At the last year’s annual meeting of the Society for Neuroscience scientists presented a very interesting research topic about our gut microbiome. They have revealed that in some way gut bacteria influence the way how the brain work. An important question arose from the mental health pont-of-view: Can we treat mental and neurological diseases by tinkering with our gut microbiome?
Metabolic studies investigating the mechanics of cancer cell proliferation have been critical to understanding resource allocation driving tumorigenesis. Generally, proliferating cells eschew efficient energy production in favour of metabolic pathways that generate the essential macromolecular building blocks necessary to grow in size and number, classically termed the Warburg effect.
Lyme disease is the most common vector-borne illness in the world. It is a tick-borne illness that afflicts around 60,000 people worldwide every year. Although the mortality rate is low, the diagnosis is complex as doctors must rely upon highly variable symptoms and indirect measures of infection when offering diagnoses.